| 原料品名 | regorafenib |
|---|---|
| 原料中文名称 | 瑞戈非尼 |
| 英文别名 | BAY 73-4506; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY 73-4506(Regorafenib); 4-[4-({[4-chioro-3-(trifluoroMethyl)phenyl]carbaMoyl}aMino)-3-fluorophenoxy]-pyridine-2-carboxylic acid MethylaMide; Regorafenib (BAY 73-4506); 4-[4-[[[[4-Chloro-3-(trifluoroMethyl)phenyl]aMino]carbonyl]aMino]-3-fluorophenoxy]-N-Methyl-2-pyridinecarboxaMide; 4-[4-[N'-(4-Chloro-3-trifluoroMethylphenyl)ureido]-3- fluorophenoxy]pyridine-2-carboxylic Acid MethylaMide |
| 中文别名 | 五氟丙酸钠盐;REGORAFENIB;BAY 73-4506;SORAFENIB;BAY-73-4506;BAY 73 4506;格非尼相关杂质;雷戈非尼;瑞戈非尼无水物;4-[4-({[4-氯-3-(三氟甲基)苯基]氨基甲酰}氨基)-3-氟苯氧基]-N-甲基吡啶-2-甲酰胺;REGORAFENIB BAY 73-4507 BAYER HEALTHCARE (SEE ALSO COLORECTAL,LUNG,STOMACH)PHASE II(REGORAFENIB)PHARM |
| 化学名称 | 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide |
| 分子式 | C21H15ClF4N4O3 |
| 分子量 | 519.27634 |
| CAS号 | 755037-03-7 |
| 结构式图片 | 暂无权限 |
供应商信息
| 企业名称 | Shilpa Medicare Ltd |
|---|---|
| 企业类型 | 生产商 |
| 地址 | Shilpa House,Hyderabad Road, Raichur – 584 135 ,Karnataka,India |
| 国家/地区 | 印度 |
| 公司官网 | 暂无权限 |
| 公司联系电话 | 暂无权限 |
| 公司邮箱 | 暂无权限 |
| 联系人 | 暂无权限 |
| 公司资质 | 暂无权限 |
| 公司简介 | Manufacturing started in 1989, Shilpa Medicare is a fully integrated pharmaceutical company, present across the entire pharmaceutical value chain from Research and Development, Active Pharmaceutical Ingredients, Finished Formulations, Biologicals, ODF and Nano Science and Nano Technology etc.State–of–the–art manufacturing facilities approved by USFDA, AGES-Austria, PMDA, Cofepris-Mexico, etc.,2 R&D Centres with capabilities of ANDAs, DMFs and NDDS.Qualified, experienced and trained staff to handle respective functions.Over 357 patents filed by Shilpa & its entities includes drug substances, products and polymorphs. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息(https://a.d4t.cn/GbmkGL)，或联系药智通客服17318480790（微信同号） |
扩展信息
